Grantham, Mayo, Van Otterloo & Co (GMO)’s Salesforce CRM Stock Holding History
Bought
Maintained
Sold
Other funds holding CRM
VCM
VPM
Grantham, Mayo, Van Otterloo & Co (GMO)'s CRM Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) increased its Salesforce (CRM) stake by 7.8% in Q1 2026, buying an estimated $66.6M and bringing the position to 4,425,552 shares worth $826M. The position accounts for 2.11% of the portfolio, ranked #16.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CRM in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.09B in Q4 2025. 2,671 funds tracked by Wall St. Rank hold CRM as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 4,425,552 shares of Salesforce worth $826M as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) bought 321,519 Salesforce shares in Q1 2026, an estimated $66.6M.
- Salesforce made up 2.11% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #16 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Salesforce in Q3 2020 and has held it in 23 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Salesforce position peaked at $1.09B in Q4 2025.
- 2,671 funds tracked by Wall St. Rank held Salesforce as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.